Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1654 of 6351
-
Can a One-Two punch tame overgrown wound tissue?
Disease control CancelledThis randomized controlled trial aims to compare the efficacy of silver nitrate, triamcinolone, and a successive use of both treatments in managing hypergranulation tissue in traumatic wounds. Conducted over a four-year period at UPMC Mercy, the study will involve patients presen…
Phase 2/3 • Sponsor: Francesco Egro • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI reads blood flow to predict if heart stents will work
Knowledge-focused Recruiting nowThe primary aim of this study is to evaluate changes in absolute coronary flow and pressure before and after percutaneous coronary intervention in calcified lesions. The secondary aim is to use a machine learning model to predict the outcome of the intervention.
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Artificial intelligence may spot gum disease from a simple photo
Diagnosis Ongoingthis study aims to use AI to diagnose the stages of gingivitis
Sponsor: Al-Azhar University • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
Your DNA may decide how well exercise and diet work for weight loss
Knowledge-focused CompletedThis study evaluated whether differences in the MC4R rs17782313 gene variant and metabolic health status were associated with different responses to a 12-week exercise and dietary intervention in adult men with obesity. A total of 40 men aged 18 to 59 years with obesity particip…
Sponsor: Harbin Sport University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Color therapy in the delivery room: a new weapon against labor pain?
Symptom relief OngoingThis randomized controlled trial was conducted to compare the effects of focusing on warm- and cool-color visuals during labor on labor pain, state anxiety, childbirth comfort, and labor duration. Nulliparous pregnant women were randomly assigned to warm- or cool-color visual foc…
Sponsor: Balikesir University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Could a new set of dentures sharpen an aging mind?
Knowledge-focused CompletedPatients over the age of 60 who do not currently have any removable dentures but require them will be included in the study. Patients who will receive complete dentures and those who will receive partial dentures will be assessed in separate groups. Before the fabrication of the …
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New drug zilucoplan shows promise for muscle weakness in myasthenia gravis patients
Disease control Recruiting nowThis study called "Multicenter Retrospective Study on the Short- and Medium-Term Efficacy and Tolerance of Zilucoplan Therapy in a Cohort of French Patients with Anti-AChR Myasthenia Gravis", is investigating the effects of a new treatment called Zilucoplan (generic name: ZILBRYS…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
AI-Powered insulin dosing shows promise for diabetes control
Disease control CompletedThe goal of this clinical trial is to learn if an intelligent insulin-dosing decision support system can improve glycemic control in adults with type 2 diabetes who are starting basal insulin therapy. The trial also aims to evaluate the safety of using this system for insulin dos…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for tough lymphoma: chemo beads target bulky tumors
Disease control Recruiting nowCurrent exploration of local therapies for large Diffuse Large B-Cell Lymphoma (DLBCL) masses remains in its infancy. This study aims to retrospectively evaluate the safety, efficacy, and tolerability of Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) for treat…
Sponsor: Ting YANG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New sedative could be safer for frail patients during medical procedures
Symptom relief OngoingRemimazolam is a new, ultra-short-acting benzodiazepine approved in Romania for procedural sedation. It shows significant clinical benefits compared to other sedatives like Propofol or Midazolam, especially in elderly or high-risk patients. Advantages include better hemodynamic s…
Phase 4 • Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Own cells implanted in brain to fight Parkinson's
Disease control OngoingThis clinical study is designed to explore the safety and tolerability of UX-DA001. It will also explore if UX-DA001 works to improve motor function in subjects with Parkinson's disease. UX-DA001 manufactured from participant's own cells will differentiate into mature dopaminergi…
Phase 1 • Sponsor: Shanghai UniXell Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Smarter radiation aims to spare breast cancer patients from painful side effects
Symptom relief Recruiting now* Prospective, open-label, bi-center study, assessing the clinical outcomes of adaptive breast radiotherapy with ETHOS in hypersensitive patients. * Bi-centric with ETHOS center : ICM (Institut du Cancer de Montpellier) and ISC (Institut Sainte Catherine) Avignon * 500 patients w…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Heart fix in one go: new study combines two procedures for AFib patients
Disease control Recruiting nowIn patients with non-valvular AF, at high stroke risk, and who are ineligible for long-term oral anticoagulation LAAC could be an alternative to anticoagulation and safety and efficacy has been shown in several studies and registries.8 While PVI and LAAC are both conducted in the…
Sponsor: Asklepios proresearch • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI tool aims to speed up kawasaki disease diagnosis in kids
Diagnosis Recruiting nowEvaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.
Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Poo test could spare thousands from unpleasant camera exams
Diagnosis Recruiting nowIn the United Kingdom, over 25,000 patients have an operation for bowel cancer each year. After their operation, patients are monitored with a colonoscopy (camera test of the bowel) approximately 3 years after their operation, to look for any possible return of the cancer. Colono…
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New combo aims to free myelofibrosis patients from frequent blood transfusions
Disease control Recruiting nowThe purpose of this Phase 2 study is to evaluate the efficacy and safety of momelotinib (MMB) in combination with luspatercept (LUSPA) in participants with transfusion dependence (TD) primary myelofibrosis (PMF) or Post-polycythemia vera (PV)/ essential thrombocythemia (ET) myelo…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Experimental Cell-Drug combo takes on tough leukemia
Disease control OngoingPhase I, open-label study to assess the safety, feasibility, pharmacokinetics, and preliminary efficacy of CART123 cells given in combination with ruxolitinib in patients with relapsed or refractory acute myeloid leukemia (AML). All subjects will receive a single infusion of CART…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a Follow-Up drug deepen remission in myeloma patients?
Disease control OngoingThis study is designed to evaluate if treatment with adjuvant nivolumab improves depth of response in patients with relapsed refractory multiple myeloma (RRMM) who achieve a less-than-ideal response to idecaptagene vicleucel.
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New immune drug targets common cancer mutation in early trial
Disease control Recruiting nowPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.
Phase 1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Heart CT Follow-Up could cut heart attacks in Non-Obstructive disease
Disease control Recruiting nowThe primary objective of this study is to evaluate whether a management strategy based on coronary computed tomography angiography (CCTA) for patients with non-obstructive coronary artery disease can improve the LDL-C target achievement rate compared to a traditional management s…
Sponsor: Zhang longjiang,MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC